ArticleCancer research2011

Human CD59 inhibitor sensitizes rituximab-resistant lymphoma cells to complement-mediated cytolysis.

Weiguo Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.